Cargando…
CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by Augmenting a Regulatory Immune Response
BACKGROUND: Accumulating evidence suggests that the balance between pathogenic effector T cells (Teffs) and regulatory T cells (Tregs) may be important for controlling atherosclerotic disease. We hypothesized that a combination therapy with anti‐CD3 antibody (CD3‐Ab) and IL‐2/anti‐IL‐2 monoclonal an...
Autores principales: | Kasahara, Kazuyuki, Sasaki, Naoto, Yamashita, Tomoya, Kita, Tomoyuki, Yodoi, Keiko, Sasaki, Yoshihiro, Takeda, Masafumi, Hirata, Ken‐ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187475/ https://www.ncbi.nlm.nih.gov/pubmed/24755152 http://dx.doi.org/10.1161/JAHA.113.000719 |
Ejemplares similares
-
Depletion of Foxp3(+) regulatory T cells augments CD4(+) T cell immune responses in atherosclerosis-prone hypercholesterolemic mice
por: Kasahara, Kazuyuki, et al.
Publicado: (2022) -
Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflammation in atherosclerosis
por: Kasahara, Kazuyuki, et al.
Publicado: (2017) -
Ultraviolet B Exposure Inhibits Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Mice by Expanding CD4(+)Foxp3(+) Regulatory T Cells
por: Hayashi, Tomohiro, et al.
Publicado: (2017) -
Recent Advances on the Role and Therapeutic Potential of Regulatory T Cells in Atherosclerosis
por: Tanaka, Toru, et al.
Publicado: (2021) -
CD3 Antibody and IL‐2 Complex Combination Therapy Inhibits Atherosclerosis by
Augmenting a Regulatory Immune Response
Publicado: (2015)